Literature DB >> 12213388

Role of the aryl hydrocarbon receptor in cell cycle regulation.

Alvaro Puga1, Ying Xia, Cornelis Elferink.   

Abstract

Traditionally, the aryl hydrocarbon receptor (AHR) is considered to be a ligand-activated receptor and transcription factor responsible for the induction of drug-metabolizing enzymes. Its role in the combinatorial matrix of cell functions was neatly established long before the first report of an AHR cDNA sequence was published. Only recently, other functions of this protein have begun to be recognized. This review addresses novel findings relating to AHR functions that have resulted from experimental approaches markedly outside traditional receptor analyses. Here we examine the aspects of AHR biology relevant to its role in cell cycle regulation, from the activation of mitogen-activated protein kinases to the cross-talk between AHR and the RAS pathway and the functional significance of the interaction between AHR and the retinoblastoma protein. We have attempted to provide the reader with a balanced interpretation of the evidence, highlighting areas of consensus as well as areas still being contested.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12213388     DOI: 10.1016/s0009-2797(02)00069-8

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  46 in total

1.  Aryl hydrocarbon receptor modulation of estrogen receptor α-mediated gene regulation by a multimeric chromatin complex involving the two receptors and the coregulator RIP140.

Authors:  Zeynep Madak-Erdogan; Benita S Katzenellenbogen
Journal:  Toxicol Sci       Date:  2011-11-09       Impact factor: 4.849

2.  Activation of the aryl hydrocarbon receptor during pregnancy in the mouse alters mammary development through direct effects on stromal and epithelial tissues.

Authors:  Betina J Lew; Ravikumar Manickam; B Paige Lawrence
Journal:  Biol Reprod       Date:  2011-01-26       Impact factor: 4.285

3.  The aryl hydrocarbon receptor contributes to the proliferation of human medulloblastoma cells.

Authors:  Daniel P Dever; Lisa A Opanashuk
Journal:  Mol Pharmacol       Date:  2012-02-06       Impact factor: 4.436

4.  Insulin like growth factor 2 regulation of aryl hydrocarbon receptor in MCF-7 breast cancer cells.

Authors:  Justin K Tomblin; Travis B Salisbury
Journal:  Biochem Biophys Res Commun       Date:  2013-12-28       Impact factor: 3.575

Review 5.  Regulation of constitutive and inducible AHR signaling: complex interactions involving the AHR repressor.

Authors:  Mark E Hahn; Lenka L Allan; David H Sherr
Journal:  Biochem Pharmacol       Date:  2008-09-20       Impact factor: 5.858

Review 6.  Aryl hydrocarbon receptor ligands in cancer: friend and foe.

Authors:  Iain A Murray; Andrew D Patterson; Gary H Perdew
Journal:  Nat Rev Cancer       Date:  2014-12       Impact factor: 60.716

7.  Neural precursor cell proliferation is disrupted through activation of the aryl hydrocarbon receptor by 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  Sarah E Latchney; Daniel T Lioy; Ellen C Henry; Thomas A Gasiewicz; Frederick G Strathmann; Margot Mayer-Pröschel; Lisa A Opanashuk
Journal:  Stem Cells Dev       Date:  2010-08-31       Impact factor: 3.272

Review 8.  The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways.

Authors:  Alvaro Puga; Ci Ma; Jennifer L Marlowe
Journal:  Biochem Pharmacol       Date:  2008-09-05       Impact factor: 5.858

9.  Multiphoton spectral analysis of benzo[a]pyrene uptake and metabolism in breast epithelial cell lines.

Authors:  Rola Barhoumi; Jeffrey M Catania; Alan R Parrish; Igbal Awooda; Evelyn Tiffany-Castiglioni; Stephen Safe; Robert C Burghardt
Journal:  J Toxicol Sci       Date:  2009-02       Impact factor: 2.196

10.  Aryl hydrocarbon receptor (AHR) in the cnidarian Nematostella vectensis: comparative expression, protein interactions, and ligand binding.

Authors:  Adam M Reitzel; Yale J Passamaneck; Sibel I Karchner; Diana G Franks; Mark Q Martindale; Ann M Tarrant; Mark E Hahn
Journal:  Dev Genes Evol       Date:  2013-11-29       Impact factor: 0.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.